BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML ... News-Medical.net Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a ... |
